(NASDAQ: ANGO) Angiodynamics's forecast annual revenue growth rate of -3.11% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.23%.
Angiodynamics's revenue in 2024 is $324,008,000.On average, 2 Wall Street analysts forecast ANGO's revenue for 2024 to be $10,843,563,174, with the lowest ANGO revenue forecast at $10,840,358,811, and the highest ANGO revenue forecast at $10,846,767,536. On average, 3 Wall Street analysts forecast ANGO's revenue for 2025 to be $11,515,277,692, with the lowest ANGO revenue forecast at $11,450,389,349, and the highest ANGO revenue forecast at $11,615,814,570.
In 2026, ANGO is forecast to generate $15,030,864,054 in revenue, with the lowest revenue forecast at $15,030,864,054 and the highest revenue forecast at $15,030,864,054.